BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9391131)

  • 21. Abnormalities in stress proteins in prion diseases.
    Tatzelt J; Voellmy R; Welch WJ
    Cell Mol Neurobiol; 1998 Dec; 18(6):721-9. PubMed ID: 9876878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prion protein diversity and disease in the transmissible spongiform encephalopathies.
    Priola SA
    Adv Protein Chem; 2001; 57():1-27. PubMed ID: 11447687
    [No Abstract]   [Full Text] [Related]  

  • 24. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
    Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
    PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
    Vorberg I; Raines A; Priola SA
    J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
    Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
    Laurent M
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
    Weissmann C
    FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion infection: seeded fibrillization or more?
    Birkmann E; Riesner D
    Prion; 2008; 2(2):67-72. PubMed ID: 19098436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family.
    Edenhofer F; Rieger R; Famulok M; Wendler W; Weiss S; Winnacker EL
    J Virol; 1996 Jul; 70(7):4724-8. PubMed ID: 8676499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro conversion of normal prion protein into pathologic isoforms.
    Bossers A; Rigter A; de Vries R; Smits MA
    Clin Lab Med; 2003 Mar; 23(1):227-47. PubMed ID: 12733434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion diseases and their biochemical mechanisms.
    Cobb NJ; Surewicz WK
    Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion seeded conversion and amplification assays.
    OrrĂº CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.